Jiajing Lu

Tongji University School of Medicine

1
Article
Overview
Articles
This action will reload the page results.
Journal article

Ixekizumab four-week dosing is comparable to two-week dosing in psoriasis patients and reduces treatment costs: experience in a real-world setting over a 12-week period

In European Journal of Dermatology (2022/5 Vol. 32)